1. Introduction
===============

Macromastia, or breast hypertrophy, can cause disabling physical symptoms in women, and emotional burden.^\[[@R1]\]^ Reduction mammoplasty is the preferred procedure to alleviate symptoms in these patients.^\[[@R2]--[@R4]\]^ Despite the proven benefits to patients, there is a hesitation in performing reduction mammoplasty in the obese (body mass index (BMI) \>30) population and some insurers require the patient to lose weight in order to reach a permissible maximum weight (20% over their ideal body weight)^\[[@R5]\]^ before approving the procedure. This may be due to the overwhelming evidence describing an association between obesity (BMI \>30) and increased postoperative complication rates,^\[[@R6]--[@R11]\]^ with the postoperative risk even greater in those classed as morbidly obese (BMI \>40),^\[[@R12],[@R13]\]^ with very few studies contradicting this maxim.^\[[@R14],[@R15]\]^ There is also the consideration of whether the macromastia and patient symptoms are sequelae of increased BMI, and if breast reduction surgery poses the best treatment option.

However, reports often describe the complications after reduction mammoplasty as minor with little effect on aesthetic outcomes.^\[[@R9],[@R10],[@R16]\]^ Indeed, increased preoperative BMI has been correlated with high satisfaction following reduction mammoplasty, however, this did not include the morbidly obese (BMI \>40).^\[[@R17]\]^ Given these findings, it can be argued that potential complication rate or dissatisfaction should not prevent those with high BMIs from undergoing breast reduction surgery.^\[[@R10],[@R14]\]^ Additionally, most existing studies have been limited in scope to a 1-year postoperative period and are thus unable to measure the long-term impact of reduction mammoplasty on patient satisfaction.^\[[@R18],[@R19]\]^

Previous studies have used a plethora of instruments to measure improvement in quality of life and patient satisfaction following reduction mammoplasty.^\[[@R20]--[@R26]\]^ We aim to assess the influence of BMI in long-term patient satisfaction following reduction mammoplasty with the use of a customized questionnaire. In addition, we aim to provide further clarification of the relationship between obesity (BMI \>30) and complications following reduction mammoplasty.

2. Methods
==========

A single-site retrospective review was performed on patients who had undergone reduction mammoplasty at the University of Maryland Medical Center from 2006 to 2013. Potential participants were identified using the CPT code 19318 (reduction mammoplasty). Only patients with 5 or more years of post-reduction follow-up were included. Patients who had oncologic reductions were deceased or did not have functional telephone numbers were excluded from the study. Eligible patients were then surveyed using a customized questionnaire to assess long-term outcomes after reduction mammoplasty. The questionnaire (Table [1](#T1){ref-type="table"}) included descriptive, open questions in order to capture patient perception of their pre- and post-operative experience. The questionnaire was designed to be brief to increase compliance and response rate. In our first stage of recruitment, letters were mailed to potential participants with information on the study and the opportunity to opt out. Then the patients were contacted by telephone to participate in our specialized survey during the phone call. The study protocol was approved by our Institutional Review Board.
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Survey questions on long-term outcomes following reduction mammoplasty.
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Patients who underwent reduction mammoplasty at the University of Maryland Medical Center from 2006 to 2013 were identified and mailed letters in the first stage of recruitment. 206 patients progressed to the second stage and were able to be contacted by telephone. Of those, 52 declined to participate in the survey, resulting in a survey response rate of 74.8% (*n* = 154). Patients who had incomplete medical records were then excluded, leaving a final total of 70 female subjects who underwent reduction mammoplasty for non-oncological indications.

Overall and aesthetic satisfaction were also surveyed following the procedure and assessed with a 5-point Likert scale with 2 verbal anchors (1 = dissatisfied, 5 = very satisfied). Patient demographics, perioperative course, and postoperative complications were extracted from electronic medical records. Preoperative BMI was classified according to the World Health Organisation Clinical Guidelines adopted by the National Institute of Health.^\[[@R27]\]^ The data were tabulated in Microsoft Excel (Microsoft 2016, Redmond, Washington) and analysis completed with IBM SPSS Software Version 24.0 (IBM Corp, Armonk, NY). Differences in continuous data were evaluated with the analysis of variance (ANOVA) and Kruskal--Wallis tests. The χ-squared test was used to calculate significance in difference between categorical data. Statistical significance was determined by a value of *P* ≤.05.

3. Results
==========

A total of 70 female subjects who underwent reduction mammoplasty for non-oncological indications were included in this study. A summary of participant demographics can be found in Table [2](#T2){ref-type="table"}. The median follow-up time was 6 years \[range: 5--12 years\]. The average preoperative BMI classification was also the most prevalent within our study: obese. The majority of patients lost weight following reduction mammoplasty (53%), with an average weight loss of 2.7 kg (6.0lbs) per person. The most common preoperative symptoms were back pain (80%) and shoulder grooving (49%). Other symptoms that were reported included posture problems (34%), rash (34%), and difficulty breathing (11%). After reduction mammoplasty, 78.6% of participants reported that preoperative symptoms were completely or mostly resolved and 71.4% stated that there was no recurrence in symptoms. 93% of patients were happy with their surgery. The median aesthetic and overall satisfaction scores on a 5-point Likert scale were high (4 and 5, respectively).
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Patient characteristics.
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Complications were identified in 17 patients (24%). Most were local wound healing complications and are listed in Table [3](#T3){ref-type="table"}. The most common complications were infection (*n* = 5) and delayed wound healing (*n* = 5).
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Complications following reduction mammoplasty.
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3.1. Preoperative BMI analysis (Table [4](#T4){ref-type="table"})
-----------------------------------------------------------------

The cohort was subdivided according to BMI to create 4 groups: normal (\<25), overweight (25--29.9), obese (30--39.9), and morbidly obese (≥40). Those with a high BMI had significantly larger amounts of breast tissue resected than the groups with lower BMIs, i.e. the higher the BMI, the greater the mass of breast tissue resected (*P* \<.01, ANOVA). Additionally, those with morbidly obese patients lost more weight since surgery than other BMI groups (*P* \<.01, ANOVA).
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Breast reduction outcomes across different body mass index (BMI) groups.
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No statistical difference was found between the BMI groups for complication rate (*P* = .79, χ-squared test), median overall satisfaction (*P* = .70, Kruskal--Wallis test) or median aesthetic satisfaction (*P* = .31, Kruskal--Wallis test).

3.2. Satisfaction analysis (Table [5](#T5){ref-type="table"})
-------------------------------------------------------------

The study group was also separated according to overall satisfaction on the 5-point Likert scale to give 3 categories: low (scores 1--2), mid (score 3), and high (scores 4--5) satisfaction. There was significance between self-reported satisfaction and aesthetic scores, as those with high satisfaction also reported a higher aesthetic satisfaction than low and mid overall satisfaction scores (*P* \<.01, Kruskal--Wallis test). There were no differences between satisfaction groups and BMI (*P* = .07, ANOVA), weight change (*P* = .314, ANOVA), or complication rate (*P* = .78, χ-squared test).
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Breast reduction outcomes according to satisfaction score.
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4. Discussion
=============

Reduction mammoplasty can improve the quality of life for patients with macromastia by alleviating physical symptoms, increasing psychosocial wellbeing, and enhancing functional status;^\[[@R2]--[@R4],[@R22]\]^ however, these reports result from short term studies that possess limited follow-up. Our study provides a 12-year perspective of patient outcomes following reduction mammoplasty. It demonstrates that women who undergo reduction mammoplasty have high levels of satisfaction that is sustained for 12 years postoperatively, as well as resolution of physical symptomatology.

We did not find any difference in postoperative complication rate or satisfaction between BMI groups. This conflicts with most of the current literature^\[[@R7]--[@R10]\]^ that describes increased postoperative complications in patients with high BMI classifications. The literature also describes longer operative times and increased hospitalization costs in those with larger body habitus. However, it provides evidence to those who advocate for reduction mammoplasty in the obese population;^\[[@R14]\]^ the long-term benefits of breast reduction surgery (high patient satisfaction, resolution of symptoms) appear to exceed the risks of postoperative complications and increased healthcare burden. Additionally, we found that those with an increased BMI had a larger mass of breast tissue resected which correlates with the literature.^\[[@R20]\]^ Interestingly, patients with a morbidly obese BMI reported a greater weight loss than other BMI groups, perhaps due to their renewed capacity for exercise. Although caution must be taken when interpreting these results given the larger interval between the operation and survey completion and the influence of external factors that influence weight, such as emotional state and socioeconomics.

Satisfaction was independent of BMI, weight change, or complications. This is in contrast to Corridi et al^\[[@R28]\]^ who found that patients were dissatisfied with breast appearance following massive weight loss with or without preceding breast reduction surgery, suggesting that postoperative weight loss can influence patients' aesthetic assessment of their breasts. It is also possible that our lower-than-expected complication rates for obese and morbidly obese patients^\[[@R7]--[@R10]\]^ may influence the reported satisfaction. Additionally, in contrast to the literature which details hematoma, delayed wound healing and partial or complete nipple loss as common complications following reduction mammoplasty in obese patients, the majority of complications within our cohort were minor. It is possible that the resolution of preoperative symptoms and functional restoration compensate for any potential minor complication suffered. In fact, Nguyen et al^\[[@R29]\]^ found that patients still reported high patient satisfaction despite experiencing a complication rate and major complications, such as decreased nipple sensitivity. We acknowledge that patients within the morbidly obese BMI classification (≥40) may also benefit from bariatric surgery and weight loss programs before breast reduction. Although weight loss is essential for improvement of overall health, it does not guarantee alleviation of macromastia symptoms^\[[@R30]\]^ but can convert patients into insurance eligible candidates for reduction mammoplasty. Therefore, surgeons also face the task of deciding the best treatment pathway for patients, and whether weight loss is advisable before reduction surgery.

Patients with low satisfaction scores cited reasons of: amount of breast tissue removed (too much or too little), return of hypertrophy or poor aesthetic outcome. Conversely, those with high overall satisfaction had significantly higher self-reported aesthetic satisfaction, that is, how well the patient perceives their breasts to look impacts how happy they are after surgery, which is not a new notion.^\[[@R23],[@R31]\]^ Previous studies have reported patient outcomes following reduction mammoplasty at different time points and found that satisfaction is stable in the immediate and shot-term postoperative period.^\[[@R18],[@R19]\]^ This is supported by our finding of high overall and aesthetic satisfaction present even 12 years after breast reduction. Thus, demonstrating that reduction mammoplasty has a clinically important and robust benefit.

Our study can be separated into 2 portions: the questionnaire and the chart review; the former is limited due by potential recall bias, and the latter by its retrospective nature. Furthermore, our study only assesses postoperative patient satisfaction, while prior studies compare preoperative survey results to postoperative results.^\[[@R19],[@R20],[@R28]\]^ Due to the retrospective nature of the review, we did not have the opportunity to survey patients before their surgeries. Although a high response rate was achieved, a smaller subset of patients was included in this study due to incomplete medical records thus limiting the external validity of the results. Additionally, there was a low sample size overall and within the subgroups, thus, decreasing our statistical power and ability to assess the impact of BMI on outcomes. Thus, caution must be taken when drawing conclusions. Another significant limitation is the use of a non-validated questionnaire. Although the BREAST-Q^\[[@R32]\]^ is commonly used to evaluate patient-reported outcomes after reduction mammoplasty, we chose to implement a novel survey with questions that were tailored to capture all symptoms and the complete patient experience following reduction mammoplasty and allow a holistic evaluation of long-term outcomes. Elements were based on key themes in the BREAST-Q (excluding sexual functioning due to the impersonal nature of phone calls when discussing sensitive issues) and a 5-point Likert scale is used instead of the 4-point score. Through our qualitative-style questions, we were able to collect descriptive patient experiences. We found that all the issues raised by the patients in our study are incorporated within the BREAST-Q, highlighting its potential efficacy in assessing long term patient-related outcomes, and an avenue for further research. Additionally, our aim was to create a more focused survey that could easily be administered over the telephone to increase survey compliance and response rate, which the novel survey achieved (74.8%).

Patients with breast hypertrophy experience high levels of satisfaction after reduction mammoplasty independent of BMI. Additionally, satisfaction was not impacted by postoperative complications, or amount of breast tissue resected. Complication rates were not significantly different between different BMI groups. We advocate against the exclusion of patients from breast reduction surgery due to BMI alone and fear of increased complication rate strictly based on BMI; instead BMI must form part of the patient\'s overall health assessment and treatment plan, wherein a responsible preoperative counseling should include recommendation for weight loss before an elective procedure such as breast reduction for obese patients.
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